Relmada Therapeutics, Inc. (RLMD)
7.21
+0.04
(+0.56%)
USD |
NASDAQ |
May 21, 16:00
7.22
+0.01
(+0.14%)
After-Hours: 19:59
Relmada Therapeutics Accounts Payable (Quarterly) : 5.731M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 1.10M |
| AN2 Therapeutics, Inc. | 2.615M |
| Corcept Therapeutics, Inc. | 33.31M |
| Assertio Holdings, Inc. | 5.913M |
| Johnson & Johnson | 10.46B |